Request Appointment
530 East 74th StreetNew York, NY 10021
Overview of Dr. Drilon
I am a medical oncologist who specializes in early drug development and thoracic oncology.
Education & Training
University of the Philippines College of MedicineClass of 2004
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2019 - 2027
NY State Medical License 2013 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
Publications & Presentations
PubMed
- Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells.Juhyeon Son, Lily L Remsing Rix, Bin Fang, Eric A Welsh, Nicole V Bremer
Molecular Oncology. 2026-04-01 - Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.Sarah Waliany, Alissa J Cooper, Stephen V Liu, Oliver Gautschi, Julia K Rotow
Clinical Cancer Research. 2026-03-16 - Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers.Emily A Miao, Beow Yeap, Sameh Daher, Meghanne Lomibao, Fangdi Sun
JCO Precision Oncology. 2026-03-01
Press Mentions
- Dr Eric K. Singhi’s Top 5 Studies from WCLC 2025: A Thoracic Oncologist’s PerspectiveSeptember 22nd, 2025
“Impressive” New Data Signal Big Changes Ahead in ROS1-Mutated NSCLC CareSeptember 16th, 2025- Zidesamtinib Shows Early Signs of Efficacy, Durability in Pretreated ROS1-Positive NSCLCSeptember 11th, 2025
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
